ERBB2 and breast carcinoma: ErbB receptor tyrosine kinases epidermal growth factor receptor (EGFR) and ErbB2 (neu, HER2) are often overexpressed, amplified, or mutated in many forms of cancer, including breast cancer, making them important therapeutic targets [77,78].